Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11228083rdf:typepubmed:Citationlld:pubmed
pubmed-article:11228083lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:11228083lifeskim:mentionsumls-concept:C0027051lld:lifeskim
pubmed-article:11228083lifeskim:mentionsumls-concept:C0021753lld:lifeskim
pubmed-article:11228083lifeskim:mentionsumls-concept:C0021760lld:lifeskim
pubmed-article:11228083lifeskim:mentionsumls-concept:C0063695lld:lifeskim
pubmed-article:11228083lifeskim:mentionsumls-concept:C1749467lld:lifeskim
pubmed-article:11228083lifeskim:mentionsumls-concept:C1456820lld:lifeskim
pubmed-article:11228083lifeskim:mentionsumls-concept:C0699826lld:lifeskim
pubmed-article:11228083lifeskim:mentionsumls-concept:C0175630lld:lifeskim
pubmed-article:11228083pubmed:issue2lld:pubmed
pubmed-article:11228083pubmed:dateCreated2001-2-28lld:pubmed
pubmed-article:11228083pubmed:abstractTextThe changes in serum concentrations of cytokines such as interleukin-1 (IL-1) beta, interleukin-6 (IL-6), tumor necrosis factor (TNF) alpha and a soluble-intercellular adhesion molecule (sICAM-1) has been investigated in patients with stable angina and acute myocardial infarction. Thirty-four patients with stable angina (SA), 15 with acute myocardial infarction (AMI), and 20 subjects in the control (C) group were included in the study. The mean serum concentrations of sICAM-1, IL-1-beta, IL-6, and TNF-alpha differed significantly among the three groups. Serum concentrations of IL-1 beta, sICAM-1, and TNF-alpha were comparable in the AMI and SA groups and higher than those found in the C group (p < 0.001). The serum concentration of IL-6 was more than twice as high in the AMI group as compared to the other two groups (p < 0.001). The mean serum concentrations of IL-1 beta, TNF-alpha, and IL-6 were comparable in the AMI and SA groups and higher than in the C group.lld:pubmed
pubmed-article:11228083pubmed:languageenglld:pubmed
pubmed-article:11228083pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11228083pubmed:citationSubsetIMlld:pubmed
pubmed-article:11228083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11228083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11228083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11228083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11228083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11228083pubmed:statusMEDLINElld:pubmed
pubmed-article:11228083pubmed:monthFeblld:pubmed
pubmed-article:11228083pubmed:issn0003-3197lld:pubmed
pubmed-article:11228083pubmed:authorpubmed-author:TikizHHlld:pubmed
pubmed-article:11228083pubmed:authorpubmed-author:COLEA FAFlld:pubmed
pubmed-article:11228083pubmed:authorpubmed-author:KorkmazSSlld:pubmed
pubmed-article:11228083pubmed:authorpubmed-author:SigmanTTlld:pubmed
pubmed-article:11228083pubmed:authorpubmed-author:BalbayYYlld:pubmed
pubmed-article:11228083pubmed:authorpubmed-author:BaptisteR JRJlld:pubmed
pubmed-article:11228083pubmed:issnTypePrintlld:pubmed
pubmed-article:11228083pubmed:volume52lld:pubmed
pubmed-article:11228083pubmed:ownerNLMlld:pubmed
pubmed-article:11228083pubmed:authorsCompleteYlld:pubmed
pubmed-article:11228083pubmed:pagination109-14lld:pubmed
pubmed-article:11228083pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:11228083pubmed:meshHeadingpubmed-meshheading:11228083...lld:pubmed
pubmed-article:11228083pubmed:meshHeadingpubmed-meshheading:11228083...lld:pubmed
pubmed-article:11228083pubmed:meshHeadingpubmed-meshheading:11228083...lld:pubmed
pubmed-article:11228083pubmed:meshHeadingpubmed-meshheading:11228083...lld:pubmed
pubmed-article:11228083pubmed:meshHeadingpubmed-meshheading:11228083...lld:pubmed
pubmed-article:11228083pubmed:meshHeadingpubmed-meshheading:11228083...lld:pubmed
pubmed-article:11228083pubmed:meshHeadingpubmed-meshheading:11228083...lld:pubmed
pubmed-article:11228083pubmed:meshHeadingpubmed-meshheading:11228083...lld:pubmed
pubmed-article:11228083pubmed:meshHeadingpubmed-meshheading:11228083...lld:pubmed
pubmed-article:11228083pubmed:meshHeadingpubmed-meshheading:11228083...lld:pubmed
pubmed-article:11228083pubmed:meshHeadingpubmed-meshheading:11228083...lld:pubmed
pubmed-article:11228083pubmed:meshHeadingpubmed-meshheading:11228083...lld:pubmed
pubmed-article:11228083pubmed:meshHeadingpubmed-meshheading:11228083...lld:pubmed
pubmed-article:11228083pubmed:meshHeadingpubmed-meshheading:11228083...lld:pubmed
pubmed-article:11228083pubmed:year2001lld:pubmed
pubmed-article:11228083pubmed:articleTitleCirculating interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha, and soluble ICAM-1 in patients with chronic stable angina and myocardial infarction.lld:pubmed
pubmed-article:11228083pubmed:affiliationDepartment of Cardiology, Türkiye Yüksek Ihtisas Hospital, Ankara, Turkey.lld:pubmed
pubmed-article:11228083pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11228083lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11228083lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11228083lld:pubmed